August 4, 2025

Integer Holdings Corporation (ITGR) Stock Analysis: A 32% Potential Upside in the Healthcare Sector

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector specializing in medical devices, presents an intriguing opportunity for investors seeking exposure to the dynamic world of medical..

Avidity Biosciences (RNA): Investor Outlook Reveals 85% Potential Upside Amid Biotech Innovations

Avidity Biosciences, Inc. (RNA), a pioneering biotechnology firm based in San Diego, California, stands as a beacon of innovation in the healthcare sector with its unique approach to RNA therapeutics...

Henry Schein, Inc. (HSIC) Investor Outlook: Navigating a Flat Market with a 11.57% Potential Upside

Henry Schein, Inc. (HSIC), a stalwart in the medical distribution industry, presents an intriguing case for investors looking to balance stability with growth potential. With a market capitalization of $8.5..

Revolution Medicines, Inc. (RVMD) Investor Outlook: Unpacking the 97% Potential Upside

Revolution Medicines, Inc. (NASDAQ: RVMD), a clinical-stage biotechnology company, is making waves in the healthcare sector with its focus on precision oncology. The company is headquartered in Redwood City, California,..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Unveiling a 15.65% Potential Upside with Promising Biotech Advances

For individual investors keeping an eye on the biotechnology sector, TG Therapeutics, Inc. (NASDAQ: TGTX) presents a compelling opportunity with its significant potential upside of 15.65%. As a leader in..

Rhythm Pharmaceuticals (RYTM) Investor Outlook: Analyzing a Potential 18% Upside in Biotech’s Growth Journey

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) has recently caught the attention of investors with its compelling market dynamics, positioned firmly within the biotechnology sector. Headquartered in Boston, Massachusetts, the company focuses..

McKesson Corporation (MCK): Investor Outlook on Healthcare Giant with 11.59% Potential Upside

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, has long been a cornerstone in the medical distribution industry. With a significant market capitalization of $87.28 billion, McKesson operates..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: A 71.91% Potential Upside Drives Investor Attention

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a prominent player in the biotechnology sector focusing on central nervous system (CNS) disorders, has been capturing investor interest with its significant growth potential and..

Koninklijke Philips N.V. (PHG): Analyst Ratings Suggest 23.83% Upside Potential for Healthcare Giant

Koninklijke Philips N.V. (PHG), the Dutch healthcare and medical devices corporation, presents an intriguing prospect for investors seeking exposure to the healthcare sector. With a market capitalization of $25.15 billion,..

Qiagen N.V. (QGEN) Stock Analysis: A Healthcare Leader with Steady Growth and Limited Upside

Qiagen N.V. (NYSE: QGEN), a prominent player in the healthcare sector, is making waves in the Diagnostics & Research industry. With a robust market capitalization of $10.81 billion, Qiagen is..

ICON plc (ICLR) Stock Analysis: Evaluating a 29.86% Potential Upside for Investors

ICON plc (NASDAQ: ICLR), a prominent player in the healthcare sector specializing in diagnostics and research, presents an intriguing opportunity for investors with its substantial potential upside. With a market..

Globus Medical, Inc. (GMED) Stock Analysis: Navigating a 57.67% Potential Upside with Innovative Healthcare Solutions

Investors with a keen eye on the healthcare sector may find Globus Medical, Inc. (NYSE: GMED) a compelling consideration, particularly given its promising potential upside of 57.67%. This Audubon, Pennsylvania-based..

Vaxcyte, Inc. (PCVX) Investor Outlook: Exploring a 280.83% Upside Potential

Investors with a keen interest in the biotechnology sector may find Vaxcyte, Inc. (NASDAQ: PCVX) an intriguing prospect. With its current market capitalization standing at $4.26 billion, Vaxcyte is positioned..

ADMA Biologics Inc (ADMA)

⚠️ No article content returned.

..

Waters Corporation (WAT): Analyst Ratings Show Potential 28.82% Upside — What Investors Need to Know

Waters Corporation (NYSE: WAT), a leading player in the healthcare sector’s diagnostics and research industry, is drawing attention from investors with its strategic market positioning and promising growth prospects. Headquartered..

Novartis AG (NVS) Stock Analysis: Navigating Growth with a Strong Dividend Yield and Robust Revenue Expansion

Novartis AG (NVS), a heavyweight in the healthcare sector, stands as a formidable player in the global pharmaceutical market. Headquartered in Basel, Switzerland, the company is renowned for its innovative..

Solventum Corporation (SOLV) Investor Outlook: Examining a Promising 18.3% Potential Upside

Solventum Corporation (NYSE: SOLV), a prominent player in the healthcare sector, offers a diverse portfolio of medical solutions that serve both consumer and professional markets. With a market capitalization of..

Humana Inc. (HUM) Stock Analysis: Potential 17% Upside Amid Healthcare Sector Dynamics

Humana Inc. (NYSE: HUM), a formidable player in the healthcare sector, offers a compelling case for investors seeking exposure to the healthcare plans industry. With a market capitalization of $29.74..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating Growth in Healthcare with a 14.20% Revenue Surge

Medpace Holdings, Inc. (NASDAQ: MEDP) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. Based in Cincinnati, Ohio, and operating across North America,..

UnitedHealth Group (UNH) Stock Analysis: Exploring a Potential 40.87% Upside

UnitedHealth Group Incorporated (NYSE: UNH), a leader in the healthcare sector, has long been a staple for investors seeking stability and growth. As a diversified healthcare company, UnitedHealth operates through..

Search

Funds

August 4, 2025

Search

Funds

August 4, 2025

FTSE 100

Funds